Jubilant Life Sciences LtdBSE -0.63 % today said it has received approval from the US health regulator to market generic version AstraZeneca’s Seroquel used for the treatment of schizophrenia and acute manic episodes associated with bipolar disorder.

The abbreviated new drug applications (ANDAs) approval from the US Food and Drug Administration is for Quetiapine Fumarate tablet, generic version AstraZeneca’s Seroquel is in strength of 25 mg (base).

“We expect to l ..